World's Best Scientists 2026 revealed!
Heather L. Davis

Heather L. Davis

D-Index & Metrics

Immunology

D-Index
66
Citations
17895
World Ranking
2740
National Ranking
115

Overview

Heather L. Davis is affiliated with Sanofi in France and has contributed extensively to medical research, with a primary focus on immunotherapy, infectious diseases, and surgical outcomes. Their body of work spans multiple intersecting fields including medicine, surgery, molecular biology, immunology, pulmonary and respiratory medicine, and epidemiology.

Their research topics emphasize immunotherapy and immune responses, hepatitis B virus studies, RNA interference and gene delivery, cardiac, anesthesia and surgical outcomes, enhanced recovery after surgery, abdominal surgery and complications, as well as esophageal and gastrointestinal pathology.

Heather L. Davis has published research in various prominent venues, including:

  • British Journal of Surgery
  • The Breast
  • Gut
  • Vaccines
  • Frontiers in Immunology

Their recent published papers include:

  • Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989, 2024, Gut
  • mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model, 2024, Vaccines
  • Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice, 2022, Frontiers in Immunology
  • Can the Remote Use of a Peak Flow Meter Predict Severity of Subglottic Stenosis and Surgical Timing?, 2022, The Laryngoscope
  • OS-032 Long-term hepatitis B surface antigen response after finite treatment with siRNAs ARC-520 or JNJ-3989, 2024, Journal of Hepatology

Frequent collaborators in their research include Kirk Bowling, Lung-Yi Mak, Christine I. Wooddell, Thomas Schluep, and James Hamilton. These co-authors have worked alongside Davis on multiple occasions, contributing to interdisciplinary studies particularly relevant to their fields of expertise.

Best Publications

  • CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen

    Heather L. Davis;Risini Weeranta;Thomas J. Waldschmidt;Lorraine Tygrett

  • Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

    Gunther Hartmann;Risini D. Weeratna;Zuhair K. Ballas;Zuhair K. Ballas;Paul Payette

  • Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

    Jörg Vollmer;Risini Weeratna;Paul Payette;Marion Jurk

  • DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

    Heather L. Davis;Heather L. Davis;Marie-Louise Michel;Robert G. Whalen

  • CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

    Cynthia L. Brazolot Millan;Risini Weeratna;Arthur M. Krieg;Claire-Anne Siegrist

  • Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

    Arthur M. Krieg;Tong Wu;Risini Weeratna;Susan M. Efler

  • Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle

    Heather L. Davis;Barbara A. Demeneix;Béatrice Quantin;Josée Coulombe

  • The role of CpG dinucleotides in DNA vaccines.

    Arthur M. Krieg;Arthur M. Krieg;Ae-Kyung Yi;Joachim Schorr;Heather L. Davis

  • CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B ® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

    C.L. Cooper;H.L. Davis;M.L. Morris;S.M. Efler

  • CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

    Risini D Weeratna;Michael J McCluskie;Yu Xu;Yu Xu;Heather L Davis

  • DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

    Marie-Louise Michel;Heather L. Davis;Martin Schleef;Maryline Mancini

  • CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

    Michael J. McCluskie;Heather L. Davis

  • Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs

    Zuhair K. Ballas;Arthur M. Krieg;Arthur M. Krieg;Arthur M. Krieg;Thomas Warren;Wendy Rasmussen;Wendy Rasmussen

  • Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist.

    Arthur M. Krieg;Susan M. Efler;Michael Wittpoth;Mohammed J. Al Adhami

  • Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.

    C.L Cooper;H.L Davis;M.L Morris;S.M Efler

  • DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.

    Heather L. Davis;Michael J. McCluskie;John L. Gerin;Robert H. Purcell

  • Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract

    W. Scott Gallichan;Robert N. Woolstencroft;Tina Guarasci;Michael J. McCluskie;Michael J. McCluskie

  • Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.

    Michael J. McCluskie;Michael J. McCluskie;Cynthia L. Brazolot Millan;Robert A. Gramzinski;Harriet L. Robinson

  • Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen.

    Heather L Davis;Marie-Louise Michel;Maryline Mancini;Martin Schleef

  • CpG Oligodeoxynucleotides Can Circumvent the Th2 Polarization of Neonatal Responses to Vaccines But May Fail to Fully Redirect Th2 Responses Established by Neonatal Priming

    Jiri Kovarik;Paola Bozzotti;Laurie Love-Homan;Maria Pihlgren

Frequent Co-Authors

Arthur M. Krieg
Arthur M. Krieg University of Massachusetts Chan Medical School
Marie-Louise Michel
Marie-Louise Michel Institut Pasteur
Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Pierre Tiollais
Pierre Tiollais Institut Pasteur
Claire-Anne Siegrist
Claire-Anne Siegrist University of Geneva
Jonathan B. Angel
Jonathan B. Angel University of Ottawa
Barbara A. Demeneix
Barbara A. Demeneix Centre national de la recherche scientifique, CNRS
Bernard J. Jasmin
Bernard J. Jasmin University of Ottawa
Isa K. Mushahwar
Isa K. Mushahwar Abbott (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career paths in healthcare and research. Many professionals choose to complement their scientific background by pursuing nursing degrees, which provide practical clinical skills and expand job opportunities. For non-nurses interested in entering the nursing field, enrolling in online BSN programs for non nurses offers a flexible and efficient way to get started.

Advanced practice roles are also popular, with numerous nurses advancing through accelerated FNP programs that help them gain family nurse practitioner certification quickly. Those seeking specialization often explore pathways like acute care NP certification, which focuses on managing critically ill patients and enhances career flexibility.

Salary potential is a crucial consideration when planning your career. For instance, understanding the DNP salary by state can inform decisions about where to practice and which certifications to pursue, maximizing your financial return.

Combining immunology knowledge with these nursing qualifications can lead to rewarding opportunities in clinical research, healthcare leadership, and specialized patient care. Exploring these related online degrees and career pathways can be a strategic move for long-term success.

Best Scientists Citing Heather L. Davis

Trending Scientists